Active Ingredient(s): Sparfloxacin
FDA Approved: * December 19, 1996
Pharm Company: * MYLAN
Category: Antibiotics

Sparfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections. It has a controversial safety profile.[1] It was patented in 1985 and approved for medical use in 1993.[2] Zagam is no longer available in the United States. Contents 1 Medical uses 2 Adverse reactions 3 Pharmacological properties 4 Mechanism of action 5 See also 6 References Medical uses The compound is indicated for treating community-acquired lower respiratory... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.